AdaptHealth (AHCO) Amortization of Deferred Charges (2019 - 2026)
AdaptHealth's (AHCO) quarterly Amortization of Deferred Charges came in at $1.2 million in Q1 2026, down 7.56% year-on-year from $1.3 million in Q1 2025, and down 5.65% quarter-over-quarter from $1.3 million in Q4 2025.
AdaptHealth (AHCO) Amortization of Deferred Charges (2019 - 2026) Analysis & Trends
AdaptHealth's Amortization of Deferred Charges history runs 8 years deep, the most recent figure standing at $1.2 million for Q1 2026.
- On a quarterly basis, Amortization of Deferred Charges fell 7.56% year-over-year to $1.2 million in Q1 2026; TTM through Mar 2026 was $5.6 million, a 248.03% increase from a year earlier, with the FY2025 full-year figure at $5.7 million, changed 0.49% from the prior year.
- Amortization of Deferred Charges declined to $1.2 million in Q1 2026 per AHCO's latest filing, from $1.3 million in the prior quarter.
- Across five years, Amortization of Deferred Charges topped out at $23.7 million in Q3 2023 and bottomed at -$21.1 million in Q4 2023.
- The 5-year median for Amortization of Deferred Charges is $1.3 million (2022), against an average of $1.4 million.
- Biggest YoY gain for Amortization of Deferred Charges was 1709.93% in 2023; the steepest drop was 1713.84% in 2023.
- Year by year, Amortization of Deferred Charges stood at $1.3 million in 2022, then plunged by 1713.84% to -$21.1 million in 2023, then increased by 8.87% to -$19.2 million in 2024, then surged by 106.53% to $1.3 million in 2025, then declined by 5.65% to $1.2 million in 2026.
- Per Business Quant, the three latest AHCO Amortization of Deferred Charges figures stand at $1.2 million (Q1 2026), $1.3 million (Q4 2025), and -$10.9 million (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 182.32 Bn | 175.02 Bn | 6.27 Bn |
| 2 | Stryker | 128.75 Bn | 125.88 Bn | 3.81 Bn |
| 3 | Medtronic | 107.83 Bn | 98.61 Bn | 6.41 Bn |
| 4 | Boston Scientific | 67.61 Bn | 66.15 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 48.13 Bn | 44.45 Bn | 1.29 Bn |
| 6 | Dexcom | 28.26 Bn | 27.14 Bn | 750.30 Mn |
| 7 | GE HealthCare Technologies | 27.78 Bn | 25.50 Bn | 1.98 Bn |
| 8 | Smith & Nephew | 26.99 Bn | 26.41 Bn | - |
| 9 | Koninklijke Philips | 23.92 Bn | 20.80 Bn | 2.07 Bn |
| 10 | AdaptHealth | 1.49 Bn | 1.45 Bn | 111.50 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 1.19 Mn |
| Mar 31, 2026 | 1.19 Mn |
| Dec 31, 2025 | 1.26 Mn |
| Dec 31, 2025 | 1.26 Mn |
| Sep 30, 2025 | -10.86 Mn |
| Sep 30, 2025 | -10.86 Mn |
| Jun 30, 2025 | 14.02 Mn |
| Jun 30, 2025 | 14.02 Mn |
| Mar 31, 2025 | 1.28 Mn |
| Mar 31, 2025 | 1.28 Mn |
| Dec 31, 2024 | -19.24 Mn |
| Dec 31, 2024 | -19.24 Mn |
| Sep 30, 2024 | 7.13 Mn |
| Sep 30, 2024 | 7.13 Mn |
| Jun 30, 2024 | 7.04 Mn |
| Jun 30, 2024 | 7.04 Mn |
| Mar 31, 2024 | 10.73 Mn |
| Mar 31, 2024 | 10.73 Mn |
| Dec 31, 2023 | -21.11 Mn |
| Dec 31, 2023 | -21.11 Mn |